- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Novartis India's shareholders have overwhelmingly approved all four Ordinary Resolutions at the 77th Annual General Meeting. Key approvals include the audited financial statements for the year ended March 31, 2025, and the final dividend declaration. Shareholders also approved the appointment of Mr. Falin Majmudar as a Director and MK Saraf & Associates LLP as Secretarial Auditors. For instance, the financial statements received 1,75,03,128 votes in favor, demonstrating strong investor confidence in the company's operations and financial health moving forward. This confirms crucial governance and financial decisions.